An intracoronary injection of nitrite during primary PCI does not reduce infarct size in STEMI patients, according to a small, randomized proof-of-concept trial published in the January 30, 2015, ...
The coronary slow-flow phenomenon, defined as spontaneously delayed flow in the absence of obstructive coronary artery disease, can be effectively treated with the channel-channel blocker nicardipine, ...
The ENTIRE-TIMI 23 trial, showing a promising result with the low molecular weight (LMW) heparin enoxaparin, given instead of unfractionated heparin with the thrombolytic agent tenecteplase (TNK), has ...
Interv Cardiol. 2011;3(6):705-712. Altogether, the usefulness and merit of the contemporary thrombus grading classifications are widely accepted (Box 4). However, certain limitations should be ...
To the Editor: Sabatine et al. (March 24 issue) 1 demonstrated in the Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)–Thrombolysis in Myocardial Infarction (TIMI) 28 trial that clopidogrel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results